Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Otsuka Holdings Co Ltd (JP:4578)
:4578
Holding JP:4578?
Track your performance easily
Earnings Data
Report Date
Feb 14, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
77.05Last Year’s EPS
-12.76Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 14, 2018
|% Change Since: -10.98%
|Next Earnings Date:Aug 08, 2018
Earnings Call Sentiment|Positive
The earnings call highlighted strong growth in revenue and business profit, driven by pharmaceutical and nutraceutical segments. Forecasts have been revised upward, and there is an acquisition to further enhance drug discovery capabilities. However, there were some negatives, such as impairment losses and a decrease in certain revenues. Overall, the positive aspects significantly outweigh the negatives, indicating a strong performance and optimistic outlook.Company Guidance
During the Q2 2024 earnings call for 4578.T, the executives provided detailed guidance reflecting significant growth in both their pharmaceutical and nutraceutical segments. Revenue increased by 17.0% year-on-year to JPY 1,108.9 billion, while business profit surged by 37.8% to JPY 213.6 billion, driven primarily by strong sales of Core 2 pharmaceutical products like ABILIFY MAINTENA and JYNARQUE, and nutraceuticals, particularly in the For Women’s Health category. Despite an impairment loss on AVP-786, net profit rose by 5.1% due to finance income. The company also revised its full-year forecast upwards, with revenue now expected to reach JPY 2,315 billion and business profit JPY 390 billion. Nutraceutical revenue saw a notable increase, achieving over a 20% growth rate to JPY 271.8 billion, fueled by the expansion of products like Bonafide and Nature Made. Additionally, the company announced plans for share repurchases amounting to JPY 50 billion as part of their shareholder return policy.Significant Revenue and Business Profit Growth
Revenue increased by 17.0% to JPY 1,108.9 billion and business profit increased by 37.8% to JPY 213.6 billion year-on-year, led by strong sales in pharmaceutical and nutraceutical businesses.
Pharmaceutical Business Success
Revenue for the pharmaceutical business increased by 17.9% year-on-year to JPY 766.7 billion, achieving 108% of the initial plan, driven by Core 2 products, ABILIFY MAINTENA, and JYNARQUE.
Strong Nutraceutical Business Performance
Revenue in the nutraceutical business grew by over 20% to JPY 271.8 billion, with significant growth in all three categories: For Women's Health (56.9%), For Climate & Environmental Risk (13%), and For Healthier Life (25.5%).
Positive Outlook and Revised Forecast
Full year revenue forecast revised up by JPY 175 billion to JPY 2,315 billion, and business profit forecast increased by JPY 60 billion to JPY 390 billion.
Acquisition for Growth
Acquisition of a company in Boston for drug discovery technology announced, aiming to enhance growth and expand capabilities.
---
JP:4578 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
JP:4578 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 31, 2024 | ¥9095.37 | ¥9207.58 | +1.23% |
| Aug 01, 2024 | ¥7709.06 | ¥7435.98 | -3.54% |
| Apr 30, 2024 | ¥6269.52 | ¥6635.65 | +5.84% |
| Feb 14, 2024 | ¥5274.47 | ¥5348.29 | +1.40% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Otsuka Holdings Co Ltd (JP:4578) report earnings?
Otsuka Holdings Co Ltd (JP:4578) is schdueled to report earning on Feb 14, 2025, TBA Not Confirmed.
What is Otsuka Holdings Co Ltd (JP:4578) earnings time?
Otsuka Holdings Co Ltd (JP:4578) earnings time is at Feb 14, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Otsuka Holdings Co Ltd stock?
The P/E ratio of Otsuka Holdings Co is N/A.
What is JP:4578 EPS forecast?
JP:4578 EPS forecast for the fiscal quarter 2024 (Q4) is 77.05.
---